4.8 Review

Pharmacologic agents targeting autophagy

期刊

JOURNAL OF CLINICAL INVESTIGATION
卷 125, 期 1, 页码 5-13

出版社

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI73937

关键词

-

资金

  1. National Institute of Neurological Disorders and Stroke [1R01NS082257]
  2. National Institute on Aging [R37 AG012859]
  3. Ellison Foundation
  4. Ake Wibergs Foundation
  5. Lars Hiertas Memorial Foundation
  6. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082257] Funding Source: NIH RePORTER
  7. NATIONAL INSTITUTE ON AGING [R37AG012859, R01AG012859] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Autophagy is an important intracellular catabolic mechanism critically involved in regulating tissue homeostasis. The implication of autophagy in human diseases and the need to understand its regulatory mechanisms in mammalian cells have stimulated research efforts that led to the development of high-throughput screening protocols and small-molecule modulators that can activate or inhibit autophagy. Herein we review the current landscape in the development of screening technology as well as the molecules and pharmacologic agents targeting the regulatory mechanisms of autophagy. We also evaluate the potential therapeutic application of these compounds in different human pathologies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据